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Streptococcus agalactiae, the Lanceﬁ  eld group B strep-
tococcus (GBS) long recognized as a mammalian pathogen, 
is an emerging concern with regard to ﬁ  sh. We show that 
a GBS serotype Ia multilocus sequence type ST-7 isolate 
from a clinical case of human neonatal meningitis caused 
disease and death in Nile tilapia (Oreochromis niloticus).
S
treptococcus agalactiae, group B streptococcus (GBS), 
has a broad host range and is pathogenic to mammals, 
reptiles, amphibians, and ﬁ  sh (1). This organism has also 
been identiﬁ  ed in aquatic mammals, both captive and wild 
bottlenose dolphins (Tursiops truncatus) (2,3). GBS causes 
mastitis in cattle and meningitis in human neonates (4). It 
also causes meningoencephalitis in ﬁ  sh (5,6). Since the 
ﬁ  rst report of GBS in hatchery-reared freshwater ﬁ  sh in 
the United States in 1966 (7), reports of piscine GBS have 
increased. Piscine GBS, like human and bovine GBS, is 
found worldwide and affects a variety of freshwater and 
marine ﬁ  sh under a broad spectrum of environmental con-
ditions (6,8).
Sustained emergence of human GBS neonatal disease 
for undetermined reasons has spurred many GBS genomic 
diversity studies. Acquisition of bovine GBS by humans 
has been proposed as 1 plausible explanation (9). Human 
and bovine GBS isolates have been considered genetically 
distinct populations (10) and as related populations arising 
from a common ancestor, presumably bovine (1,9).
Two lineages of bovine GBS (multilocus sequence 
type ST-23 and ST-61) appear to have a genetic relation-
ship with human GBS. Human serotype Ia strains in the 
ST-23 lineage and human serotype III ST-17 strains are 
related to bovine ST-61 strains and frequently associated 
with neonatal infections (10,11). Phylogenetic studies have 
focused on homogeneity or heterogeneity of lineages and 
association with carried or invasive GBS. Many research-
ers believe that GBS serotype does not correlate with evo-
lutionary relationships. Strains of different serotypes and 
sequence types often share more genes than strains of the 
same serotype and contain carried and invasive strains, 
traits suggestive of opportunistic pathogenicity (9,11,12).
Whether GBS is a zoonotic organism has not been ade-
quately explored. Conclusions of genomic studies can only 
infer virulence, infectivity, and transfer between different 
animals on the basis of serologic, molecular, and compu-
tational analyses of GBS isolates. Bovine GBS isolates of 
unknown sequence type were not infective for Nile tilapia 
(Oreochromis niloticus) (13). However, potential for infec-
tion between homothermic hosts and poikilothermic ani-
mals has been demonstrated.
GBS transmission from mice to reptiles occurs by 
oral ingestion (14). In tilapia (mean weight 40 g) infectiv-
ity studies with a dolphin GBS isolate, disease signs and a 
mortality rate of 90% were noted within 6 days postinocu-
lation with 107 CFU/ﬁ  sh (3). Piscine, dolphin, and human 
GBS isolates have been reported (15) to share the same se-
rotype (Ia) and sequence type (ST-7) as that reported from 
human GBS carried (strain from a person with no evidence 
of disease) and neonatal invasive strains from Japan (4) and 
North America (isolate A909) (11). This ﬁ  nding indicates 
that piscine and dolphin GBS isolates may have been de-
rived from human sources and caused a ﬁ  sh epidemic in 
Kuwait and that serotype Ia ST-7 GBS may cause a zoono-
sis (15). Non–ST-7 ﬁ  sh isolates are widely divergent from 
other animal GBS isolates (12,15). We conducted a study 
of experimentally induced infection to determine whether a 
human serotype, Ia ST-7 GBS isolate, could cause disease 
signs and death in ﬁ  sh.
The Study
Nile tilapia served as experimental ﬁ  sh because they 
could be held at warm water temperatures closer to the 
normal human body temperature of 37°C than other avail-
able ﬁ  sh species. Seven groups of 10 tilapia (mean ± SE 
weight 28.20 ± 0.51 g) each were housed in 57-L aquari-
ums at the Aquatic Animal Health Research Laboratory 
(Chestertown, MD, USA). All tanks were supplied with 
ﬂ  ow-through dechlorinated tap water and 2 submersible 
heaters and air stones to maintain desired water tempera-
ture and dissolved oxygen (DO) levels. Water quality 
(mean ± SE temperature, DO, and ammonia concentra-
tion) was measured daily by using a YSI 85 meter (Yel-
low Springs Instrument Co., Yellow Springs, OH, USA) 
and a Fresh Water Aquaculture Kit (Model AG-2; LaM-
otte Company, Chestertown, MD, USA). Temperature 
was 32.1 ± 0.09°C, DO was 4.2 ± 0.14 mg/L, and am-
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monia concentration was 0.74 ± 0.08 mg/L. Fish were fed 
daily (4% of bodyweight) with Aquamax Grower 400 ﬁ  sh 
feed (Purina, Brentwood, MO, USA) and maintained and 
handled according to Institutional Animal Care and Use 
Committee–approved guidelines.
The serotype Ia ST-7 human GBS isolate (ID# 510012) 
was obtained from a patient in Japan who had neonatal 
meningitis. The isolate was cultured overnight on 5% sheep 
blood agar (SBA; Remel, Lenexa, KS, USA) at 32°C. Be-
fore the study, the isolate was passed through 5 Nile tilapia 
(weight 18.4 ± 0.48 g) 1 time each by intraperitoneal injec-
tion of 107 CFU of GBS/ﬁ  sh. Specimens from a ﬁ  sh that 
died 3 days postchallenge were cultured on SBA, and GBS 
was recovered from nostrils, intestines, posterior kidney, 
and brain. One GBS colony isolated from brain was cul-
tured on SBA, typed as GBS by Lanceﬁ  eld grouping (6), 
and used for experimental infection.
Serial dilutions of the GBS isolate were prepared in 
tryptic soy broth (TSB; Remel), and 10 ﬁ  sh (weight 28.2 
± 0.51 g) were each injected intraperitoneally with 0.1 mL 
of inoculum at 107, 106, 105, 104, 103, or 102 CFU/ﬁ  sh. Ten 
control ﬁ  sh were injected with 0.1 mL of TSB only. Fish 
were placed in separate 57-L aquariums at 32°C according 
to dose and monitored daily for signs of disease and death 
for 14 days postchallenge. Moribund ﬁ  sh were humanely 
euthanized by an overdose of tricaine methanesulfonate 
(MS-222; Argent Chemical Laboratories, Redmond, WA, 
USA).
Bacterial samples were obtained from nostrils and 
brains of all moribund or dead ﬁ  sh and cultured on SBA 
at 32°C for 24 h for GBS. Identiﬁ   cation of GBS was 
performed by using methods of Evans et al. (6) and the 
BIOLOG MicroLog3 Microbial Identiﬁ  cation  System 
(BIOLOG, Hayward, CA, USA) according to the manufac-
turer’s instructions. BIOLOG results were compared with a 
Microlog database (www.biolog.com/mID_product.html); 
a similarity index >0.50 and high probability (>90%) were 
considered a strong conﬁ  rmation for GBS.
Within 7 days postchallenge, the 102, 103, and 107 
CFU/ﬁ  sh groups had a mean cumulative mortality rate of 
11.7% (7/60) (Figure). Overall, deaths occurred on day 2 
and the mortality rate reached 20% after 14 days of obser-
vation. Deaths after day 10 occurred in ﬁ  sh that received 
106 CFU. Sampled organs were negative for GBS and 
deaths were attributed to tank mate aggression to weak-
ened ﬁ  sh. A linear dose response was not seen. Deaths 
occurred at low (102–103 CFU/ﬁ  sh) and high (107 CFU/
ﬁ  sh) doses but not at median doses (Table). Disease signs 
in tilapia exposed to human GBS were lethargy, anorexia, 
dark coloration, opaque eyes, and remaining stationary at 
the bottom of the tank.
All sampled organs from ﬁ  sh dying within 7 days of 
infection contained β-hemolytic, gram-positive, oxidase-
negative, catalase-negative bacteria. BIOLOG analysis 
conﬁ  rmed  identiﬁ   cation as GBS (similarity index 0.79, 
probability 100%). None of the TBS-injected control ﬁ  sh 
showed signs of disease or died.
Conclusions
Deaths among experimentally infected Nile tilapia in-
dicate that an Ia ST-7 human GBS isolate can be pathogen-
ic to ﬁ  sh. Such isolates have been associated with human 
(4,12) and ﬁ  sh disease as well as with a marine mammal 
sampled during a GBS ﬁ  sh kill (15). The human isolate was 
virulent in tilapia at 102, 103, 106, and 107 CFU/ﬁ  sh, and 
GBS was reisolated from diseased ﬁ  sh. These experimen-
tal ﬁ  ndings suggest GBS transmission between mammals 
and ﬁ  sh and that GBS-induced ﬁ  sh epidemics can origi-
nate from mammalian sources. Although we studied only 1 
human isolate, other isolates or isolates repeatedly passed 
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Figure. Mortality rates for 60 Nile tilapia at all doses (black line) and 
10 tilapia each challenged with a human Streptococcus agalactiae 
isolate (#510012): 102 (gray line), 103 (green line), 106 (red line), 
and 107 (blue line) CFU/ﬁ  sh. No deaths occurred at 104 and 105 
CFU/ﬁ  sh or in tryptic soy broth controls.
Table. Mortality rates among Nile tilapia (Oreochromis niloticus)
infected with Streptococcus agalactiae*
Dose (CFU/fish)  No. (%)† deaths 
Tryptic soy broth (control)  0
a
10
2 3 (30)
ab
10
3 1( 1 0 )
a
10
4 0
a
10
5 0
a
10
6 5( 5 0 )
b
10
7 3 (30)
ab
*Ten fish per dose group were intraperitoneally injected with human S.
agalactiae/fish or tryptic soy broth and observed for 14 days postchallenge 
at a water temperature of 32°C. 
†Superscript letters indicate significant differences (p<0.05) in percentage 
mortality rates between groups, determined by using the SAS program 
(SAS Institute, Cary, NC, USA) lifetest procedure (Kaplan-Meier method). through ﬁ  sh may be more virulent. Susceptibility to GBS 
may also be enhanced by suboptimal environmental condi-
tions, such as low DO, high ammonia levels, euthrophica-
tion, harmful algae, and changing or extreme water tem-
peratures (5,6). Future histopathologic investigations may 
characterize the distribution and nature of the host response 
to human GBS.
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